AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2016
Oct 24, 2016
33431_dirs_2016-10-24_4e697161-9e99-4132-90e5-62b6c6305d24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-10-20
Reporting Person: Midyett Ronald Lane (Chief Operations Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-10-20 | Right to Buy Restricted Stock Unit (RSU) | $ | M | 7145 | Acquired | Common Stock (7145) | Direct | |
| 2016-10-20 | Right to Buy Restricted Stock Unit (RSU) | $ | M | 7145 | Acquired | Common Stock (7145) | Direct |
Footnotes
F1: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.
F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F3: Restricted Stock Units will vest on the 2nd anniversary of the grant date and will be automatically settled in shares of common stock.
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1